Dermal and plexiform neurofibromas are peripheral nerve sheath tumors that
arise frequently in neurofibromatosis type 1. The goal of the present study
was to examine the tumorigenic properties of neurofibromin-deficient human
Schwann cells (SCs) that were found to represent a subset of SCs present i
n approximately half of the total neurofibromas examined. Highly enriched S
C cultures were established from 10 dermal and eight plexiform neurofibroma
s by selective subculture using glial growth factor-2 and laminin. These cu
ltures had low tumorigenic potential in classical in vitro assays yet sever
al unique preneoplastic properties were frequently observed, including dela
yed senescence, a lack of density-limited growth, and a strong propensity t
o spontaneously form proliferative cell aggregates rich in extracellular ma
trix. Western blot analysis failed to detect full-length neurofibromin in a
ny of the neurofibroma SC cultures, indicating that neurofibromin-deficient
SCs had a substantial growth advantage. Immunohistochemical staining of th
e originating tumors showed the majority were comprised principally of neur
ofibromin-negative SCs,whereas the remainder contained both neurofibromin-n
egative and neurofibromin-positive SCs, Lastly, engraftment of neurofibromi
n-deficient SC cultures into the peripheral nerves of scid mice consistentl
y produced persistent neurofibroma-like tumors with diffuse and often exten
sive intraneural growth. These findings indicate that neurofibromin-deficie
nt SCs are involved in neurofibroma formation and, by selective subculture,
provide a resource for the development of an in vivo model to further exam
ine the role of these mutant SCs in neurofibroma histogenesis.